Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lessnau, K. D.
Right arrow Articles by Talavera, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lessnau, K. D.
Right arrow Articles by Talavera, W.

Chest, Vol 104, 119-122, Copyright © 1993 by American College of Chest Physicians

REVIEWS

Disseminated Strongyloides stercoralis in human immunodeficiency virus- infected patients. Treatment failure and a review of the literature

KD Lessnau, S Can and W Talavera
Cabrini Medical Center, New York Medical College, New York 10003.

We describe a North American human immunodeficiency virus (HIV)- positive patient with Strongyloides stercoralis infection of the gastrointestinal tract, who required repeated "standard" courses of thiabendazole. Pulmonary infection with numerous roundworms developed, as suspected by bronchoalveolar lavage, and while he was receiving therapy, dissemination occurred. On autopsy, S stercoralis was recovered in the gastrointestinal tract, liver, lung, and heart. After a literature review, we conclude that HIV-positive patients have a higher risk of dissemination and "standard" treatment failure. This may occur without elevation of IgE or eosinophilia. Those patients may require prolonged courses of thiabendazole or alternatively ivermectin therapy.


This article has been cited by other articles:


Home page
 ChestHome page
A. M. Newberry, D. N. Williams, W. M. Stauffer, D. R. Boulware, B. R. Hendel-Paterson, and P. F. Walker
Strongyloides Hyperinfection Presenting as Acute Respiratory Failure and Gram-Negative Sepsis
Chest, November 1, 2005; 128(5): 3681 - 3684.
[Abstract] [Full Text] [PDF]

Home page
 Am J Trop Med HygHome page
M. SATOH, H. TOMA, S. KIYUNA, Y. SHIROMA, A. KOKAZE, and Y. SATO
ASSOCIATION OF A SEX-RELATED DIFFERENCE OF STRONGYLOIDES STERCORALIS-SPECIFIC IgG4 ANTIBODY TITER WITH THE EFFICACY OF TREATMENT OF STRONGYLOIDIASIS
Am J Trop Med Hyg, July 1, 2004; 71(1): 107 - 111.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Microbiol. Rev.Home page
P. B. Keiser and T. B. Nutman
Strongyloides stercoralis in the Immunocompromised Population
Clin. Microbiol. Rev., January 1, 2004; 17(1): 208 - 217.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1993 by the American College of Chest Physicians.